 State Street Corp raised its stake in shares of Jounce Therapeutics Inc NASDAQ:JNCE by 2.5 during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 418,772 shares of the companys stock after purchasing an additional 10,081 shares during the quarter. State Street Corps holdings ... 